T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis.
about
Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritisThe story of CD4+ CD28- T cells revisited: solved or still ongoing?Syk regulates multiple signaling pathways leading to CX3CL1 chemotaxis in macrophages.Rheumatoid Arthritis, Immunosenescence and the Hallmarks of AgingDefective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis.Unchecked CD70 expression on T cells lowers threshold for T cell activation in rheumatoid arthritis.CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosis.Immune aging and rheumatoid arthritis.Chemokines and chemokine receptors in arthritis.Immune aging and autoimmunity.Cells of the synovium in rheumatoid arthritis. T lymphocytes.Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activityMechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis.Antigen presentation by human microvascular endothelial cells triggers ICAM-1-dependent transendothelial protrusion by, and fractalkine-dependent transendothelial migration of, effector memory CD4+ T cellsT Cell CX3CR1 Mediates Excess Atherosclerotic Inflammation in Renal Impairment.T-cell co-stimulatory pathways in autoimmunity.Fractalkine in rheumatoid arthritis: a review to date.Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis.Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis.Developments in the scientific understanding of rheumatoid arthritis.Unusual CD4+CD28- T Cells and Their Pathogenic Role in Chronic Inflammatory Disorders.Multifaceted activities of CCR7 regulate T-cell homeostasis in health and disease.Safety, pharmacokinetics, and efficacy of E6011, an antifractalkine monoclonal antibody, in a first-in-patient phase 1/2 study on rheumatoid arthritis.The life (and death) of CD4+ CD28(null) T cells in inflammatory diseases.Fractalkine/CX3CL1 in rheumatoid arthritis.The synovium in rheumatoid arthritisSenescence marker killer cell lectin-like receptor G1 (KLRG1) contributes to TNF-α production by interaction with its soluble E-cadherin ligand in chronically inflamed joints.Fractalkine functions as a chemoattractant for osteoarthritis synovial fibroblasts and stimulates phosphorylation of mitogen-activated protein kinases and Akt.Therapeutic intervention of inflammatory/immune diseases by inhibition of the fractalkine (CX3CL1)-CX3CR1 pathway.Tissue-specific Role of CX3CR1 Expressing Immune Cells and Their Relationships with Human Disease.
P2860
Q24598633-54AC01C8-1BE8-4777-833D-7C7B650EE51EQ28082856-D4FD84F1-08AA-4D1C-ADC2-1DD13755916CQ30427232-FF2D9963-FFDB-4823-ABFB-8C0D678218D6Q33555281-7C5BB9A1-79E7-41AA-BC2A-70EA6F547CFAQ33646411-3D675B41-6157-4D0E-A70D-928D9CD62363Q33706812-F0EE84EB-5C45-4DAE-8A49-1402C6D9EED2Q34027799-6767EFF1-A8FA-484E-B300-2AF573F98FE6Q34036703-E55D2888-0836-4220-9CE2-2E25FF44D553Q34051768-B8ED5A47-E97F-4F59-ADF1-36E9ECC31FF1Q34777989-9F7F8F2C-58E6-4E10-9CDE-A708DF3295D1Q35769049-CF04D8BC-9828-4905-817F-BD782B3918E2Q36245680-19BA9117-E1BE-4133-BC5B-A2A9681A805BQ36577386-A23FC293-242D-44D1-981F-961DCC63C4C5Q36731726-6A38F53D-853B-454F-87C7-C63D23006903Q36944695-51227663-DF55-475F-ADEE-7F3AB68D93DFQ36972497-2EF34F17-98A2-479D-8094-DF568F066088Q37170088-5665703F-EE11-4F80-9282-AD426FF76E1BQ37300823-E19B496E-789B-449B-8511-665D0718AA05Q37378198-A29B2E80-210E-4A6F-A736-8E693934E557Q37454068-886A8B76-9AEE-4612-B69D-5475FC0CDE05Q37541433-67FD201A-3D4F-4F59-9F66-936891A8E1C2Q38018888-2D8CFB4C-9A2F-40CD-95BA-5A20ED7C9DB3Q38374478-7EFB3AA2-2D6A-4118-9260-9BB0AFDF2BD7Q38550407-AAA8ABC7-C9A3-4F93-9E28-1B6E37B4D83DQ38916484-83A4226F-0A52-410A-99B6-F0D051933955Q40577397-6576BC75-0F5E-4FC8-A080-B92FD1F05C5CQ44177491-3BA4529C-53D2-4F8B-A5A6-12E8D41323C6Q46080665-C90B03C0-9663-4430-BF1A-D9C97FFFD83DQ47148153-37E2CD7A-53FB-447F-83B2-12D21B37A434Q55000062-314F02E2-1E42-409D-BD31-B8E265D6B0D9
P2860
T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis.
@en
T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis.
@nl
type
label
T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis.
@en
T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis.
@nl
prefLabel
T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis.
@en
T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis.
@nl
P2093
P2860
P356
P1476
T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis.
@en
P2093
Cornelia M Weyand
Hirokazu Sawai
James Roberson
Jörg J Goronzy
Toshio Imai
Yong Wook Park
P2860
P304
P356
10.1002/ART.21140
P577
2005-05-01T00:00:00Z